Cryptococcus neoformans methionine synthase: Expression analysis and requirement for virulence

Microbiology

Volumn 150, Issue 9, 2004, Pages 3013-3023

  Pascon, Renata C ^a   Ganous, Tonya M ^a   Kingsbury, Joanne M ^a   Cox, Gary M ^a   McCusker, John H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CYCLOSPORIN A; FLUCONAZOLE; HOMOCYSTEINE; MELANIN; METHIONINE SYNTHASE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS GROWTH; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; GROWTH RATE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYCLOSPORINE; FLUCONAZOLE; GENE DELETION; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; HEAT; HOMOCYSTEINE; MELANINS; METHIONINE; MICE; MICROBIAL SENSITIVITY TESTS; MUTATION; RNA, FUNGAL; RNA, MESSENGER; TACROLIMUS; TRANSCRIPTION, GENETIC; VIRULENCE; VIRULENCE FACTORS;

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 4844231595     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.27235-0     Document Type: Article

References (55)

1. Alspaugh, J. A., Perfect, J. R. & Heitman, J. (1997). Cryptococcus neoformans mating and virulence are regulated by the G-protein α subunit GPA1 and cAMP. Genes Dev 11, 3206-3217.
2. Alspaugh, J. A., Pukkila-Worley, R., Harashima, T., Cavallo, L. M., Funnell, D., Cox, G. M., Perfect, J. R., Kronstad, J. W. & Heitman, J. (2002). Adenylyl cyclase functions downstream of the Gα protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans. Eukaryot Cell 1, 75-84.
3. Banerjee, R. V. & Matthews, R. G. (1990). Cobalamin-dependent methionine synthase. FASEB J 4, 1450-1459.
4. Barrett, D. (2002). From natural products to clinically useful antifungals. Biochim Biophys Acta 1587, 224-233.
5. Boguslawski, G. & Stetler, D. A. (1979). Aspects of physiology of Histoplasma capsulatum. Mycopathologia 67, 17-24.
6. Brzywczy, J., Sieânko, M., Kucharska, A. & Paszewski, A. (2002). Sulphur amino acid synthesis in Schizosaccharomyces pombe represents a specific variant of sulphur metabolism in fungi. Yeast 19, 29-35.
7. Bulmer, G. S., Sans, M. D. & Gunn, C. M. (1967). Cryptococcus neoformans. I. Nonencapsulated mutants. J Bacteriol 94, 1475-1479.
8. Cox, G. M., Mukherjee, J., Cole, G. T., Casadevall, A. & Perfect, J. R. (2000). Urease as a virulence factor in experimental cryptococcosis. Infect Immun 68, 443-448.
9. Cruz, M. C., Del Poeta, M., Wang, P. & 7 other authors (2000). Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin. Antimicrob Agents Chemother 44, 143-149.
10. Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J., McCusker, J. H. & Heitman, J. (2002). Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 21, 546-559.
11. Davidson, R. C., Blankenship, J. R., Kraus, P. R., de Jesus Berrios, M., Hull, C. M., D'Souza, C., Wang, P. & Heitman, J. (2002 . A PCR-based strategy to generate integrative targeting alleles with large regions of homology. Microbiology 148, 2607-2615.
12. Debono, M. & Gordee, R. S. (1994). Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol 48, 471-497.
13. 1, fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother 44, 739-746.
14. Fromtling, R. A., Shadomy, H. J. & Jacobson, E. S. (1982). Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia 79, 23-29.
15. Galgiani, J. N. & Lewis, M. L. (1997). In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob Agents Chemother 41, 180-183.
16. Gâomez, B. L. & Nosanchuk, J. D. (2003). Melanin and fungi. Curr Opin Infect Dis 16, 91-96.
17. Ghannoum, M. A., Ibrahim, A. S., Fu, Y., Shafiq, M. C., Edwards, J. E., Jr & Criddle, R. S. (1992). Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol 30, 2881-2886.
18. Gonzâalez, J. C., Banerjee, R. V., Huang, S., Sumner, J. S. & Matthews, R. G. (1992). Comparison of cobalamin-independent and cobalamin-dependent methionine synthases from Escherichia coli: two solutions to the same chemical problem. Biochemistry 31, 6045-6056.
19. Granger, D. L., Perfect, J. R. & Durack, D. T. (1985). Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest 76, 508-516.
20. Hatanaka, H., Ariga, N., Nagai, J. & Katsuki, H. (1974). Accumulation of a sterol intermediate during reaction in the presence of homocysteine with cell-free extract of yeast. Biochem Biophys Res Commun 60, 787-793.
21. Hoffman, C. S. & Winston, F. (1987). A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57, 267-272.
22. Jakubowski, H. (1991). Proofreading in vivo: editing of homocysteine by methionyl-tRNA synthetase in the yeast Saccharomyces cerevisiae. EMBO J 10, 593-598.
23. Jakubowski, H. (2002). The determination of homocysteine-thiolactone in biological samples. Anal Biochem 308, 112-119.
24. Jakubowski, H. (2004). Molecular basis of homocysteine toxicity in humans. Cell Mol Life Sci 61, 470-487.
25. Kacprzak, M. M., Lewandowska, I., Matthews, R. G. & Paszewski, A. (2003). Transcriptional regulation of methionine synthase by homocysteine and choline in Aspergillus nidulans. Biochem J 376, 517-524.
26. Kingsbury, J. M., Yang, Z., Ganous, T. M., Cox, G. M. & McCusker, J. H. (2004a). Cryptococcus neoformans Ilv2p confers resistance to sulfometuron methyl and is required for survival at 37°C and in vivo. Microbiology 150, 1547-1558.
27. Kingsbury, J. M., Yang, Z., Ganous, T. M., Cox, G. M. & McCusker, J. H. (2004b). Novel chimeric spermidine synthase-saccharopine dehydrogenase gene (SPE3-LYS9) in the human pathogen Cryptococcus neoformans. Eukaryot Cell 3, 752-763.
28. Kwon-Chung, K. J. & Bennett, J. E. (1992). Cryptococcus. In Medical Mycology, pp. 397-446. Edited by C. Cann. Philadelphia, PA: Lea & Febiger.
29. Kwon-Chung, K. J. & Rhodes, J. C. (1986). Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 51, 218-223.
30. Maesaki, S., Marichal, P., Ashraf Hossain, M., Sanglard, D., Bossche, H. V. & Kohno, S. (1998). Synergistic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains. J Antimicrob Chemother 42, 747-753.
31. Marchetti, O., Moreillon, P., Glauser, M. P., Bille, J. & Sanglard, D. (2000a). Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother 44, 2373-2381.
32. Marchetti, O., Entenza, J. M., Sanglard, D., Bille, J., Glauser, M. P. & Moreillon, P. (2000b). Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans. Antimicrob Agents Chemother 44, 2932-2938.
33. Marchetti, O., Moreillon, P., Entenza, J. M., Vouillamoz, J., Glauser, M. P., Bille, J. & Sanglard, D. (2003). Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrob Agents Chemother 47, 1565-1570.
34. Maresca, B. & Kobayashi, G. S. (1989). Dimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi. Microbiol Rev 53, 186-209.
35. Marzluf, G. A. (1997). Molecular genetics of sulfur assimilation in filamentous fungi and yeast. Annu Rev Microbiol 51, 73-96.
36. McCammon, M. T. & Parks, L. W. (1981). Inhibition of sterol transmethylation by S-adenosylhomocysteine analogs. J Bacteriol 145, 106-112.
37. McDade, H. C. & Cox, G. M. (2001). A new dominant selectable marker for use in Cryptococcus neoformans. Med Mycol 39, 151-154.
38. Medoff, G., Painter, A. & Kobayashi, G. S. (1987). Mycelial- to yeast-phase transitions of the dimorphic fungi Blastomyces dermatitidis and Paracoccidioides brasiliensis. J Bacteriol 169, 4055-4060.
39. Odom, A., Del Poeta, M., Perfect, J. & Heitman, J. (1997a). The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob Agents Chemother 41, 156-161.
40. Odom, A., Muir, S., Lim, E., Toffaletti, D. L., Perfect, J. & Heitman, J. (1997b). Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J 16, 2576-2589.
41. Onyewu, C., Blankenship, J. R., Del Poeta, M. & Heitman, J. (2003). Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother 47, 956-964.
42. Parks, L. W. & Casey, W. M. (1995). Physiological implications of sterol biosynthesis in yeast. Annu Rev Microbiol 49, 95-116.
43. Perfect, J. R., Toffaletti, D. L. & Rude, T. H. (1993). The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Infect Immun 61, 4446-4451.
44. Pieniazek, N., Stepieân, P. P. & Paszewski, A. (1973). An Aspergillus nidulans mutant lacking cystathionine synthase: identity of L-serine sulfhydrylase with cystathionine synthase and its distinctness from O-acetyl-L-serine sulfhydrylase. Biochim Biophys Acta 297, 37-47.
45. Rose, M. D., Winston, F. & Hieter, P. (1990). Methods in Yeast Genetics: a Laboratory Course Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
46. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning; a Laboratory Manual, 2nd edn.Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
47. Sanglard, D. (2002). Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 5, 379-385.
48. Sanglard, D., Ischer, F., Marchetti, O., Entenza, J. M. & Bille, J. (2003). Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 48, 959-976.
49. Sheehan, D. J., Hitchcock, C. A. & Sibley, C. M. (1999). Current and emerging azole antifungal agents. Clin Microbiol Rev 12, 40-79.
50. Thomas, D. & Surdin-Kerjan, Y. (1997). Metabolism of sulfur amino acids in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 61, 503-532.
51. Toffaletti, D. L., Rude, T. H., Johnston, S. A., Durack, D. T. & Perfect, J. R. (1993). Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol 175, 1405-1411.
52. Vallim, M. A., Fernandes, L. & Alspaugh, J. (2004). The RAM1 gene encoding a protein-farnesyltransferase β-subunit homolog is essential in Cryptococcus neoformans. Microbiology 150, 1925-1935.
53. White, T. C., Marr, K. A. & Bowden, R. A. (1998). Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11, 382-402.
54. Yang, Z., Pascon, R. C., Alspaugh, A., Cox, G. M. & McCusker, J. H. (2002). Molecular and genetic analysis of the Cryptococcus neoformans MET3 gene and a met3 mutant. Microbiology 148, 2617-2625.
55. 2. Infect Immun 71, 6155-6164.